I. Introduction: The Quantum Leap in Consciousness Research

The resurgence of psychedelic research has catalyzed a profound paradigm shift, moving these compounds from the fringe of counterculture into the critical core of neuroscientific inquiry. This transition demands a re-evaluation not just of psychopharmacology, but of consciousness itself. The most compelling arguments emerging from this field suggest that the profound experiences induced by classical psychedelics are not merely chemical artifacts but rather the conscious mind accessing an innate, highly potent machinery already resident within the brain.

The core premise, inferred from contemporary research on altered states, is that the mechanism of psychedelic action centers not on the specific chemical structure of the substance, but on its functional capacity to disrupt the brain’s established mechanisms of filtering and self-referential stability. This leads directly to the fundamental proposition of the endogenous system hypothesis: the human brain possesses a built-in capacity for generating these alternate realities, a notion substantiated by the presence of native compounds like N,N-dimethyltryptamine (DMT).¹

This expert analysis proposes the Universal Key Hypothesis: If the endogenous psychedelic system exists, then the means to unlock the profound psychedelic state is not reliant on a specific receptor binding blueprint (such as agonizing the 5-HT_2A receptor). Instead, the key must be the activation of a final common neural pathway—a functional output. Therefore, any molecule capable of sufficiently modulating or overwhelming this system, regardless of its primary receptor target, must work, provided it hits the necessary functional threshold. This theoretical framework forces a rigorous investigation into high-dose administration of substances like cannabis, which operate through the endocannabinoid system, a pharmacologically distinct pathway.

II. Deconstructing the Altered State: Quieting the Self-Filter

The phenomenal effects of psychedelics—the complex visualizations, synesthesia, and sense of ego dissolution—can be traced back to the disruption of a crucial neural architecture: the Default Mode Network (DMN). Understanding the DMN’s function is paramount to defining the mechanism of the psychedelic state.

II.A. The Default Mode Network (DMN): The Gatekeeper of Reality

The DMN is a functionally connected network of brain regions that remains highly active when an individual is internally focused, encompassing areas involved in autobiographical memory, future planning, and self-referential thought. It is, essentially, the neurological basis for the “sense of self” ² and the generator of constant internal “chatter.”

In standard waking consciousness, the DMN acts as a highly disciplined filter. It maintains a stable, predictable, and rigid reality construct, operating effectively as a “closed default mode”.³ This system prioritizes efficiency and coherence, effectively limiting the scope of information the nervous system processes to that which is relevant to maintaining ego and physical survival.

The function of classic psychedelics is to attenuate, disrupt, or “chip away” at the cohesive functionality of the DMN.² This is not a generalized suppression of brain activity, but a targeted disorganization of the networks responsible for maintaining self-identity. This temporary dissolution of the ego-filter is the necessary precursor for the higher conscious state.

II.B. The Paradigm Shift: From Closed Filter to Open Resonator

When the filtering mechanism of the DMN—the internal “chatter network”—quiets, the nervous system undergoes a profound functional change, shifting from a closed system to what researchers describe as an “open resonator”.³

This opening allows the brain to escape its habitual, self-imposed constraints. When the normal regulatory loops break down, the nervous system starts “tuning into wider field patterns”.³ Phenomenologically, this shift manifests as the characteristic features of the psychedelic experience, including synesthesia (the blending of senses), the appearance of complex, shifting fractals, and the emergence of archetypal imagery.³ The brain’s signals are no longer filtered for efficiency but amplified for diversity, leading to a richer, if temporarily chaotic, informational landscape.

II.C. Quantifying Higher States: Neural Signal Diversity

The subjective experience of reaching a ‘higher state of consciousness’ demands objective, mathematical validation. Neuroscientists have addressed this need by quantifying brain activity complexity using indices such as entropy and Lempel-Ziv (LZ) complexity.² LZ complexity measures the diversity of neural signaling, providing a mathematical index of the level of consciousness. For example, individuals who are awake score higher on this scale than those in states of lower consciousness, such as propofol-induced anesthesia.²

Empirical studies have applied these metrics to measure spontaneous magnetoencephalographic (MEG) signals in humans under the influence of various psychedelic substances, including psilocybin, ketamine, and LSD. These studies consistently demonstrate a sustained increase in neural signal diversity—high LZ complexity scores—for psychoactive doses of these drugs, compared with the normal waking state.² This consistent observation provides scientific validation that the psychedelic state constitutes a verifiable ‘higher’ level of consciousness, defined by its quantitative increase in information processing capacity.²

The evidence reveals a crucial causal relationship: new studies show that LSD, for instance, actively “chips away” at the brain’s “sense of self” network (the DMN).² Simultaneously, it drives the sustained increase in neural complexity (the high LZ scores).² This confluence suggests that the primary purpose of the DMN is to maintain a state of order and coherence around the concept of self, which inherently limits neural diversity (low complexity). By disrupting this rigid, filtering system, psychedelics necessarily permit a wider, more diverse, and less predictable pattern of neural communication. Therefore, the core mechanism of action for any psychedelic is defined by two linked functional outputs: (1) DMN attenuation, and (2) maximizing LZ complexity. This establishes the unified neurobiological standard that any proposed effective psychedelic, including cannabis, must meet.

III. DMT: Defining the Limit of Endogenous Experience

To establish a benchmark for the maximal output of the endogenous psychedelic system, one must examine $N,N$-dimethyltryptamine (DMT). DMT provides definitive evidence that the brain is inherently capable of generating the most profound altered states known to humankind.

III.A. The Native Ligand and the Brain’s Potential

DMT is critically important because it is a naturally occurring chemical found in miniscule amounts within the human brain.¹ Its mere presence confirms that the neural machinery possesses the necessary neurochemical foundation to run the full psychedelic program internally. While the exact role and trigger for endogenous DMT release are still debated, the fact that the brain synthesizes this highly potent $5-HT_{2A}$ agonist defines the maximum capacity and potential of the endogenous psychedelic system.

III.B. The Immersive ‘Waking Dream’ State

The neurophysiological signature of externally administered DMT provides a clear target for comparison. Studies have successfully peered inside the brain to show how DMT affects human consciousness by significantly altering the brain’s electrical activity.¹ Researchers from Imperial College London have compared its powerful effects to “dreaming while awake”.¹

This state is characterized by total immersion, intense visual imagery, and strong emotional experiences, frequently involving accounts of “breakthroughs” into what users describe as an alternate reality or dimension.¹ These intense visual and subjective effects, which users describe as being completely immersed in their experience ¹, set the highest bar for the phenomenological outcome required to validate the activation of the endogenous system. The discussion around these profound experiences is widespread, confirming DMT as the benchmark for a true “breakthrough”.⁴

The observation that DMT induces a vivid “waking dream” ¹ implies a direct engagement with the brain systems responsible for complex, internal reality generation, systems that are highly active during REM sleep. Since the DMN is largely quieted during REM, the endogenous psychedelic system appears to utilize or overlap with the physiological mechanisms governing dreaming. This suggests that the endogenous system is not a chemical accident, but an evolved mechanism for periodic structural and informational resetting of the brain—a dynamic, high-entropy state essential for neural flexibility. The ‘breakthrough’ experience, therefore, is simply the conscious mind accessing this normally subconscious, high-complexity process.

IV. The Universal Key Hypothesis: Convergence on Functional Output

The consistent neurobiological response across chemically diverse compounds strongly suggests that the brain’s psychedelic response is functionally defined, rather than chemically constrained.

IV.A. The Flexibility of the Psychedelic Substratum

The central paradox in psychedelic neuroscience is the ability of chemically distinct substances to produce remarkably similar subjective and objective functional outcomes. LSD (a serotonin analog), DMT (a tryptamine), and Ketamine (an NMDA receptor antagonist) operate through fundamentally different primary receptor systems, yet all induce the functional signatures of increased LZ complexity and DMN attenuation.²

This chemical heterogeneity coupled with functional homogeneity demonstrates that the brain’s psychedelic program is largely receptor-agnostic at the macro-level. The system is highly flexible and appears designed such that multiple distinct molecular mechanisms can indirectly trigger the same critical functional change: the destabilization of the self-filter (DMN) leading to the maximization of informational complexity (LZ score).

IV.B. Bridging the Pharmacological Divide: The Need for an Indirect Modulator

The Universal Key Hypothesis becomes most provocative when applied to substances that do not interact directly with the serotonergic system. Classic psychedelics predominantly act as agonists at the $5-HT_{2A}$ receptor. Cannabis, conversely, is principally mediated by $\Delta^9$-tetrahydrocannabinol ($\Delta^9$-THC), which acts as a partial agonist of the $CB_1$ receptor, regulating the endocannabinoid system (ECS).

To validate the hypothesis—that the functional outcome is the true universal key—we must establish a plausible theoretical bridge. We propose that high-dose $CB_1$ agonism can indirectly, but effectively, achieve the necessary functional destabilization of the DMN and the resulting complexity boost. This modulation is achieved not by hijacking the $5-HT_{2A}$ receptor, but by disrupting the precise balance of excitatory and inhibitory neurotransmitters (glutamate and GABA) that the DMN relies upon to maintain its rigid, filtering coherence.

V. Cannabis and the Endogenous Spectrum: Searching for the Breakthrough Threshold

Testing the Universal Key Hypothesis requires looking for evidence that the endocannabinoid system, operating through indirect means, can reach the same level of profound DMN destabilization observed with DMT.

V.A. The Pharmacological Intersect

The $CB_1$ receptor is one of the most abundant $G$-protein coupled receptors in the mammalian brain, exhibiting high prevalence in areas critical to cognitive function and DMN activity, including the cortex and hippocampus.

The mechanism of indirect modulation centers on the ECS’s primary role as a retrograde messenger, regulating neurotransmitter release. High concentrations of $\Delta^9$-THC flood the ECS, pushing it far beyond its normal homeostatic range. Specifically, excessive $CB_1$ activation can significantly alter glutamatergic signaling in the cortex, impacting synaptic plasticity and function. The DMN’s self-referential feedback loops are highly sensitive to these excitatory/inhibitory imbalances. This induced dysregulation, rather than direct serotonergic receptor binding, may be sufficient to destabilize the DMN’s tight integration.

The experiential evidence supports this DMN instability: high-dose cannabis commonly induces severe temporal distortion, feelings of derealization, paranoia, and transient confusion—all recognized clinical signs that the brain’s filtering, predictive modeling, and integration systems (the DMN) are temporarily offline or severely impaired.

V.B. The Dose/Chemotype Dependent Window

Because cannabis works through an indirect modulatory pathway, the pharmacological effect must overcome robust standard homeostatic mechanisms. Achieving the profound functional outcome—a measurable increase in LZ complexity equivalent to a classic psychedelic state—requires an exceptionally high dose, a “breakthrough” dose, that pushes the entire system past its regulatory capacity.

Furthermore, the specific chemotype of the cannabis used likely acts as a critical modulating factor. Variations in strain profiles, including the presence of specific terpene ratios and non-$\Delta^9$-THC cannabinoids, may alter how effectively the ECS indirectly modulates the DMN’s inputs. This accounts for the observation that only highly specific, intense cannabis experiences result in profound, visual, ‘psychedelic’ states, while typical recreational use primarily yields relaxation or mild euphoria.

We are looking for the precise parameters that reveal the flexibility of the endogenous system. Since the functional output (high LZ complexity) is the consistent target, the $CB_1$ pathway must functionally replicate the DMN filter failure caused by $5-HT_{2A}$ agonism. Because the mechanism is indirect, the required input must be precise and significantly higher than typical usage. This required specificity necessitates the identification of a “Cannabinoid Complexity Trigger Dose”—the exact pharmacological input that reliably produces the full DMT-like experience.

VI. The Citizen Science Initiative: Mapping the Cannabis Breakthrough

To move this hypothesis from theoretical neuropharmacology to empirical validation, the scientific community must confront a significant data gap. We lack high-resolution, phenomenological data that rigorously links specific cannabis chemotypes and administration methods to the classic, immersive “breakthrough” state defined by DMT.¹

VI.A. Bridging the Data Gap

Traditional clinical studies often rely on standardized dosages and preparations, which may miss the critical, high-dose/high-potency combinations that might induce these extreme states. To test the Universal Key Hypothesis adequately, we must turn to the highly experienced user community—the citizen scientists—who possess the granular observational data needed to correlate indirect CB1 activation with DMN destabilization.

VI.B. The Specific Ask: Did You See It?

The goal is to filter out common high states. We are seeking reports from individuals whose cannabis experience transcended standard altered perception and reached the highest levels of immersive experience, comparable to the DMT benchmark: ego dissolution, contact with perceived entities, total immersion in a complex, alternate reality, or highly detailed, continuous geometric visual fields—the functional equivalent of a ‘waking dream’.¹ Crucially, we need to know the specifics of what was consumed and the quantity required to reach that state.

VI.C. Detailed Data Collection Protocol

To ensure the utility of community reports for rigorous neuropharmacological correlation, submissions must be structured and detailed. The required specificity is necessary to correlate indirect $CB_1$ activation with the necessary DMN destabilization and high LZ complexity. The following data points are required to map the “Cannabinoid Complexity Trigger Dose.”

Cannabis Experience Data Collection Protocol: Testing the Universal Key

Required Data Point	Purpose	Format Requirement
Compound/Strain Name & Type	To correlate specific terpene and cannabinoid profiles (chemotypes) with the breakthrough effect.	Specific Brand Name, Chemotype Classification (e.g., Sativa dominant/Type I, High-CBD Type II, or type of concentrate such as $\Delta^9$-THC distillate)
Administration Method & Dose	To establish the necessary high threshold required to destabilize the DMN via the indirect pathway.	Vaped/Smoked (Estimated grams/puffs over specific time), Edible (Specific milligram dose), Tincture (ml/mg concentration)
Subjective Intensity Level (Immersive Scale)	To confirm the experience reached the required depth to engage the endogenous system, filtering out mild high states.	Rating 1 (Mild perceptual change) to 5 (Full Breakthrough/Immersive Visuals/Ego Dissolution)
Evidence of “Seeing It” (Phenomenology)	Confirmation that the experience matches the high-complexity, low-DMN signature associated with classic psychedelics.1	Yes/No, followed by a detailed description of complex geometric forms, interaction with archetypal entities, profound synesthesia, or total immersion in an alternate reality.
Duration and Setting (Context)	External factors (set and setting) significantly modulate intensity and must be recorded to help isolate the true chemical effect from environmental cues.	Start time, Length of peak, Environment (e.g., Alone/Group, Dark/Light, Sensory Input Level)

VII. Conclusion: The Integrated Brain and the Future of Consciousness

The evidence collected regarding the neurobiology of altered states points overwhelmingly toward a unified functional mechanism: psychedelics operate by attenuating the brain’s rigid filtering system (the DMN), which functionally maximizes neural signal diversity (LZ complexity).² The existence of DMT, a native compound that defines the maximal experience, confirms that the endogenous psychedelic system is an inherent, fundamental biological capacity.¹

This reframed understanding dictates that the endogenous psychedelic system is not a pharmacological quirk confined to $5-HT_{2A}$ agonists, but a robust biological mechanism for high-complexity information processing. If high-dose cannabis, acting through the distinct $CB_1$ receptor, can achieve the same profound, immersive state—the “waking dream” of the endogenous system ¹—it would profoundly validate the Universal Key Hypothesis and prove the remarkable plasticity of this innate consciousness machinery.

We invite users whose experiences align with the demanding benchmark set by DMT to submit their detailed, structured reports based on the protocol provided. These citizen science data are vital to mapping the pharmacological spectrum of the endogenous psychedelic system and advancing the scientific understanding of consciousness beyond current receptor-specific models. The future of consciousness research depends on understanding all pathways capable of unlocking the higher, more diverse states of the integrated brain.

For more on our work and cause, consider following or signing up for newsletter or our work at woundedhealersinstitute.org or donating to our cause: HERE.

References

O’Brien, A. (2023a). Addiction as Trauma-Related Dissociation: A Phenomenological Investigation of the Addictive State. International University of Graduate Studies. (Dissertation). Retrieved at woundedhealersinstitute.org/courses/addiction-as-dissociation-model-course/

O’Brien, A. (2023b). Memory Reconsolidation in Psychedelics Therapy. In Path of the Wounded Healer: A Dissociative-Focused Phase Model for Normative and Pathological States of Consciousness: Training Manual and Guide. Albany, NY: Wounded Healers Institute. Retrieved at woundedhealersinstitute.org/courses/addiction-as-dissociation-model-course/

O’Brien, A. (2023c). Path of the Wounded Healer: A Dissociative-Focused Phase Model for Normative and Pathological States of Consciousness: Training Manual and Guide. Albany, NY: Wounded Healers Institute. Retrieved at woundedhealersinstitute.org/

O’Brien, A. (2024a). Healer and Healing: The re-education of the healer and healing professions as an advocation. Re-educational and Training Manual and Guide. Albany, NY: Wounded Healers Institute. Retrieved at woundedhealersinstitute.org/

O’Brien, A. (2024e). Path of the Wounded Healers for Thrivers: Perfectionism, Altruism, and Ambition Addictions; Re-education and training manual for Abusers, Activists, Batterers, Bullies, Enablers, Killers, Narcissists, Offenders, Parents, Perpetrators, and Warriors. Re-Education and Training Manual and Guide. Albany, NY: Wounded Healers Institute. Retrieved at woundedhealersinstitute.org/

O’Brien, A. (2025). American Made Addiction Recovery: a healer’s journey through professional recovery. Albany, NY: Wounded Healers Institute. Retrieved at woundedhealersinstitute.org/

*This is for informational and educational purposes only. For medical advice or diagnosis, consult a professional.